Invest in Neurocarrus

New first-in-class sensory neuron specific pain drug treats pain without risk of addiction

FIRST GOAL HIT (You can still invest)

$56,700

reserved by 35 investors
INVESTMENT TERMS
Future Equity
$11.25M valuation cap
Updates